
About Saived Pharma Private Limited
Data last updated:
Saived Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 June 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24233PN2012PTC143785. Its GSTIN is 27AARCS7090Q1Z6 (Maharashtra).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹30 Lakh. It is led by directors Jalindar Tukaram Deshmukh and Swati Jalindar Deshmukh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G. No. – C – 4/35 Jejuri MIDC, Pune, Maharashtra, India – 412303.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.41 Cr, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹5.29 Lakh (net margin 2.2%) and EBITDA of ₹35.87 Lakh (EBITDA margin 14.9%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 7% over five years.
The company has about 10 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Saived Pharma. As per MCA filings, the company has open charges of ₹1.18 Cr and satisfied charges of ₹1.9 Cr on record. The company has 3 deals on record (3 rights issues); the latest was in March 2018. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Olympus Lifesciences Private Limited with revenue of ₹2.43 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 5 overdue payments to 5 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website saivedpharma.co.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressG. No. – C – 4/35 Jejuri MIDC, Pune, Maharashtra, India – 412303
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Saived Pharma Private Limited
The main business activity of Saived Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Saived Pharma Private Limited FY 2025 filings available
Saived Pharma Private Limited reported revenue of ₹2.41 Cr (down 4% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Saived Pharma Private Limited
Revenue fell 4% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 7%. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Saived Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹35.87 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹5.29 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Saived Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Saived Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Saived Pharma Private Limited
Saived Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Olympus Lifesciences Private Limited | ₹2.43 Cr (FY 2024) | •••• | •••• | -29.0% | •••• | Kolkata, West Bengal, India |
| Kirvsy Pharmaceuticals Private Limited | ₹2.42 Cr (FY 2023) | •••• | •••• | -47.0% | •••• | Delhi, India |
| Grefuel Private Limited | ₹2.42 Cr (FY 2025) | •••• | •••• | 135.0% | •••• | Ankleshwar, Gujarat, India |
| Medirin Pharmaceuticals Private Limited | ₹2.42 Cr (FY 2025) | •••• | •••• | 1778.0% | •••• | Ambala Cantt, Haryana, India |
| Oxirich Healthcare Private Limited | ₹2.42 Cr (FY 2024) | •••• | •••• | 41.0% | •••• | Shahpur Jat, Delhi, India |
| Saived Pharma Private Limited this company | ₹2.41 Cr (FY 2024) | •••• | •••• | -4.0% | •••• | Pune, Maharashtra, India |
| Medigold Life Sciences Private Limited | ₹2.41 Cr (FY 2021) | •••• | •••• | 705.0% | •••• | Uruli Kanchan, Maharashtra, India |
| Fourtrax Lifestyles Private Limited | ₹2.41 Cr (FY 2025) | •••• | •••• | 46.0% | •••• | Karnal, Haryana, India |
| Indo French Laboratories Limited | ₹2.41 Cr (FY 2023) | •••• | •••• | 70.0% | •••• | Chennai, Tamil Nadu, India |
| Alcor Healthcare Private Limited | ₹2.41 Cr (FY 2025) | •••• | •••• | •••• | Chennai, Tamil Nadu, India | |
| Taurus Life Sciences Limited | ₹2.41 Cr (FY 2025) | •••• | •••• | -17.0% | •••• | Sanand, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Saived Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Saived Pharma Private Limited
Saived Pharma Private Limited is audited by B. G. VARMA & ASSOCIATES for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| B. G. VARMA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Saived Pharma Private Limited
Saived Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jalindar Tukaram Deshmukh Also directs: Associated Herbaceutical Private Limited | Director | 22 Jun 2012 | 14 Years 3 Months | Current |
| Swati Jalindar Deshmukh | Director | 22 Jun 2012 | 14 Years 3 Months | Current |
Ownership and Shareholding of Saived Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Saived Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Apr 2024 | Others | ₹60 Lakh | Open |
| 04 Apr 2024 | Others | ₹58 Lakh | Open |
| 31 May 2022 | Others | ₹75 Lakh | Satisfied |
| 25 Jun 2020 | Others | ₹11.49 Lakh | Satisfied |
| 19 May 2020 | Others | ₹3.5 Lakh | Satisfied |
Total charge records: 8 View all charges
Deals & Funding of Saived Pharma Private Limited
Saived Pharma Private Limited has 3 deals on record (3 rights issues); the latest was in March 2018.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2018 | Rights issue | ₹10 Lakh | Investors: 2 individuals |
| Aug 2015 | Rights issue | ₹6 Lakh | Investors: 2 individuals |
| Oct 2014 | Rights issue | ₹3 Lakh | Investors: 2 individuals |
Full deal history
All 3 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
MSME Payment Delays by Saived Pharma Private Limited
Saived Pharma Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 5 overdue payments to 5 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 5)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Ansar Industries | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Aryaansh Bionaturals Private Limited | •••• | •••• | •••• |
| Everest Pharma | •••• | •••• | •••• |
| Shri Ganga Ayurved Utpad Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Saived Pharma Private Limited
Saived Pharma operates one associated brand: Saived Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Formulation and distribution of Ayurvedic medicines and herbal products in India. | saivedpharma.com |
Employees and EPFO Compliance at Saived Pharma Private Limited
Saived Pharma Private Limited has a workforce of 10 employees as of Mar 28, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Saived Pharma Private Limited
Saived Pharma Private Limited has 2 board changes on record since 2012: 2 appointments. The latest: Jalindar Tukaram Deshmukh was appointed as Director on 22 Jun 2012.
10 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Saived Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Saived Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Saived Pharma Private Limited
Saived Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AARCS7090Q1Z6 | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Saived Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Saived Pharma Private Limited
Saived Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 June 2012 (14+ years old) and is registered under CIN U24233PN2012PTC143785.
Saived Pharma reported revenue of ₹2.41 Cr for FY 2024 (down 4% YoY).
Saived Pharma has 2 current directors:
- Jalindar Tukaram Deshmukh - Director
- Swati Jalindar Deshmukh - Director
Saived Pharma reported a net profit of ₹5.29 Lakh (net margin 2.2%) and EBITDA of ₹35.87 Lakh (EBITDA margin 14.9%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Saived Pharma is 3% over three years and 7% over five years. In the latest year (FY 2024) revenue fell 4%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Saived Pharma is 27AARCS7090Q1Z6, registered in Maharashtra.
The CIN (Corporate Identification Number) of Saived Pharma is U24233PN2012PTC143785. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Saived Pharma was incorporated on 22 June 2012, making it 14+ years old. It is registered with the Registrar of Companies, Pune.
Saived Pharma has 3 deals on record (3 rights issues); the latest was in March 2018.
The peers of Saived Pharma by revenue are Olympus Lifesciences Private Limited, Kirvsy Pharmaceuticals Private Limited, Grefuel Private Limited, Medirin Pharmaceuticals Private Limited, Oxirich Healthcare Private Limited and 5 more, all in the Pharma industry (Formulations).
Jalindar Tukaram Deshmukh was appointed as Director on 22 Jun 2012. Swati Jalindar Deshmukh was appointed as Director on 22 Jun 2012.
Saived Pharma has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 5 overdue payments to 5 micro and small suppliers. The latest return was filed on 29 May 2019.